Patient Buzz Series: Better Atopic Dermatitis Care
Atopic dermatitis (AD) patients have a myriad of treatment options available to them in 2026. Yet not all patients experience clear or almost clear skin. This disconnect can lead patients to doubt the adequacy of their care. Articles by Everyday Health empower patients who feel stuck or overlooked in their AD treatment. In an article on signs it’s time for a second opinion, dermatologists outlin …
Atopic dermatitis (AD) patients have a myriad of treatment options available to them in 2026. Yet not all patients experience clear or almost clear skin. This disconnect can lead patients to doubt the adequacy of their care. Articles by Everyday Health empower patients who feel stuck or overlooked in their AD treatment. In an article on signs it’s time for a second opinion, dermatologists outlin … Continue reading "Patient Buzz Series: Better Atopic Dermatitis Care"
While the importance of wearing sunscreen is often emphasized, rarely do we stop to consider how sunscreen works and why it is effective. A thorough understanding of these details is essential for dermatologists and trainees alike to feel confident navigating conversations with patients about sunscreen formulations, efficacy, and safety. At the inaugural Lab to Label Conference, Dr. Candrice Heath …
The U.S. Marine Corps’ tightened shaving rules could impact its service members with pseudofolliculitis barbae (PFB), according to NBC News. Guidance issued in March says that a service member may be discharged from the Marines if PFB persists within a year while under a four-part treatment plan. Previously, Marines with PFB resistant to topical treatment were able to receive temporary or perman …
[vc_row][vc_column][vc_column_text css=""]Despite decades of educational efforts, there is growing public skepticism over sunscreen’s safety and efficacy. Researchers from Chicago sought to synthesize the current scientific understanding of sunscreen in order to help dermatology clinicians address concerns. The findings are published in the February Journal of Drugs in Dermatology.
I intervie …